Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy

Clinical trial NCT06667154 · RECRUITING

Trial details

NCT number: NCT06667154
Sponsor: Aline Fusco Fares, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Nonsmall Cell Non-Small Cell Lung Cancer NSCLC

Start date: 2023-10-10
Primary completion: 2025-10-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.